Forrest A P
Cancer. 1977 Jun;39(6 Suppl):2813-21. doi: 10.1002/1097-0142(197706)39:6<2813::aid-cncr2820390669>3.0.co;2-8.
A survey of controlled randomized trials of orthodox therapy directed to the breast and axillary nodes has indicated that 1) if radical mastectomy is performed, postoperative radiotherapy gives no advantage over a watching policy and 2) if postoperative radical radiotherapy is given, there is no need for other than a simple mastectomy. A large multicenter trial is also indicating that simple mastectomy alone with reservation of radiotherapy for treating local recurrent disease is safe initial treatment. These results refer to survival; postoperative radiotherapy does reduce the incidence of local recurrence but this apparently can be equally well treated when it occurs. Local excision of the tumor, followed by radiotherapy, has been reported to give inferior results to a radical approach in Stage II tumors. Recognition that all these methods of local treatment fail to cure the majority of patients has emphasized the need to define the extent of the disease and to apply treatment according to that extent. We have studied a policy of selective local therapy based on this principal in which total mastectomy is combined with biopsy of the pectoral lymph nodes and further treatment by radiotherapy given only if these nodes are involved by tumor. This policy has been compared with a standard radical approach and is giving similar results. In our current Edinburgh trials, pectoral node biopsy is also used to select patients for inclusion in trials of systemic therapy.
1)如果进行根治性乳房切除术,术后放疗相较于观察策略并无优势;2)如果给予术后根治性放疗,除单纯乳房切除术外无需其他治疗。一项大型多中心试验也表明,单纯乳房切除术并保留放疗用于治疗局部复发性疾病是安全的初始治疗方法。这些结果涉及生存率;术后放疗确实能降低局部复发率,但当局部复发发生时,显然同样能得到良好治疗。据报道,对于II期肿瘤,肿瘤局部切除后再进行放疗,其效果不如根治性方法。认识到所有这些局部治疗方法都无法治愈大多数患者,这凸显了明确疾病范围并根据该范围进行治疗的必要性。我们基于这一原则研究了一种选择性局部治疗策略,即全乳房切除术联合胸肌淋巴结活检,仅当这些淋巴结被肿瘤累及才进一步给予放疗。该策略已与标准根治性方法进行比较,结果相似。在我们目前于爱丁堡进行的试验中,胸肌淋巴结活检也用于选择患者纳入全身治疗试验。